Midlife insulin resistance as a predictor for late-life cognitive function and cerebrovascular lesions

Manuscript Number: 

19-0691R1

Author(s): 
Laura L. Ekblad, Semi Helin, Saija Hurme, Jarkko Johansson, Antti Jula, Mira Karrasch, Juha Koikkalainen, Hanna Laine, Jyrki Lötjönen, Riitta Parkkola, Juha O. Rinne, Sini Toppala, Matti Viitanen

Disclosures

Laura L. Ekblad

  • Nothing to Disclose

Semi Helin

  • Nothing to Disclose

Saija Hurme

  • Nothing to Disclose

Jarkko Johansson

  • Nothing to Disclose

Antti Jula

  • Nothing to Disclose

Mira Karrasch

  • Nothing to Disclose

Juha Koikkalainen

  • Equity:
    JK is a co-founder and shareholder at Combinostics Ltd.
    Patents/Royalties
    JK is an inventor of several patents hold by Combinostics Ltd but not related to this work.

Hanna Laine

  • Nothing to Disclose

Jyrki Lötjönen

  • Equity:
    JL is a co-founder and shareholder at Combinostics Ltd
    Lecture Fees:
    JL has given educational presentations to Merck and Sanofi, paid to his institution.
    Patents/Royalties
    JL is an inventor of several patents hold by Combinostics Ltd but not related to this work.

Riitta Parkkola

  • Nothing to Disclose

Juha O. Rinne

  • Nothing to Disclose

Sini Toppala

  • Lecture Fees:
    I have received a lecture fee of 400 euros once in 2018. I was invited to speak by Lundbeck.

Matti Viitanen

  • Nothing to Disclose